ACER3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.972400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.022400E-01
Normal-vs-Stage2
8.778600E-01
Normal-vs-Stage3
1.802450E-01
Normal-vs-Stage4
9.843200E-01
Stage1-vs-Stage2
9.988000E-01
Stage1-vs-Stage3
2.952400E-01
Stage1-vs-Stage4
9.247400E-01
Stage2-vs-Stage3
1.852440E-01
Stage2-vs-Stage4
8.867400E-01
Stage3-vs-Stage4
3.234800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.839000E-01
Normal-vs-AfricanAmerican
9.357800E-01
Normal-vs-Asian
4.339000E-01
Caucasian-vs-AfricanAmerican
6.123800E-01
Caucasian-vs-Asian
3.613800E-01
AfricanAmerican-vs-Asian
2.880600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.863400E-01
Normal-vs-Female
6.720400E-01
Male-vs-Female
3.954800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.251800E-01
Normal-vs-Age(41-60Yrs)
8.595800E-01
Normal-vs-Age(61-80Yrs)
6.811000E-01
Normal-vs-Age(81-100Yrs)
4.950600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.205400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.076600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.792800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.820300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.135600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.564600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.662600E-01
Normal-vs-Daily Drinker
4.745600E-01
Normal-vs-Weekly Drinker
6.227200E-01
Normal-vs-Occasional Drinker
5.461800E-01
Normal-vs-Social Drinker
8.682800E-01
Non Drinker-vs-Daily Drinker
5.863400E-01
Non Drinker-vs-Weekly Drinker
8.538000E-01
Non Drinker-vs-Occasional Drinker
8.684200E-01
Non Drinker-vs-Social Drinker
2.890200E-01
Daily Drinker-vs-Weekly Drinker
5.463400E-01
Daily Drinker-vs-Occasional Drinker
7.480600E-01
Daily Drinker-vs-Social Drinker
1.544030E-01
Weekly Drinker-vs-Occasional Drinker
7.602000E-01
Weekly Drinker-vs-Social Drinker
3.689800E-01
Occasional Drinker-vs-Social Drinker
2.479600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.613800E-01
Normal-vs-Grade 2
1.148950E-01
Normal-vs-Grade 3
1.708580E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.472200E-01
Grade 1-vs-Grade 3
8.397600E-02
Grade 1-vs-Grade 4
4.613800E-01
Grade 2-vs-Grade 3
2.936600E-01
Grade 2-vs-Grade 4
1.148950E-01
Grade 3-vs-Grade 4
1.708580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.878000E-01
Normal-vs-NonDiabetic
6.801600E-01
Diabetic-vs-NonDiabetic
8.656400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.915000E-01
Normal-vs-NoPancreatitis
6.947000E-01
Pancreatitis-vs-NoPancreatitis
6.927000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.961800E-01
Normal-vs-N1
8.822800E-01
N0-vs-N1
4.672400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.348600E-01
Normal-vs-TP53-NonMutant
5.157800E-01
TP53-Mutant-vs-TP53-NonMutant
3.567200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
